Hightower 6 M Holding, LLC Eagle Pharmaceuticals, Inc. Transaction History
Hightower 6 M Holding, LLC
- $1.11 Billion
- Q3 2022
A detailed history of Hightower 6 M Holding, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Hightower 6 M Holding, LLC holds 8,862 shares of EGRX stock, worth $10,457. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,862
Previous 9,115
2.78%
Holding current value
$10,457
Previous $405,000
42.22%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding EGRX
# of Institutions
52Shares Held
5.33MCall Options Held
1MPut Options Held
100-
Nantahala Capital Management, LLC New Canaan, CT2.36MShares$2.78 Million0.52% of portfolio
-
Aqr Capital Management LLC Greenwich, CT375KShares$442,4900.0% of portfolio
-
Black Rock Inc. New York, NY353KShares$416,2590.0% of portfolio
-
Marshall Wace, LLP London, X0223KShares$263,5560.0% of portfolio
-
Morgan Stanley New York, NY192KShares$226,8110.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $15.4M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...